Health Canada

Health Canada

October 13, 2009 16:07 ET

Health Canada: Note to Editors

OTTAWA, ONTARIO--(Marketwire - Oct. 13, 2009) - Health Canada today released the October 2009 issue of the Canadian Adverse Reaction Newsletter (CARN).

This issue includes an article on intravenous immune globulin (IVIG) and its suspected association with hemolysis, a serious blood disorder. IVIG is a blood product used to treat certain conditions of the immune system.

It also contains an article on an incident involving a brand-name drug, Revatio, that was not recognized as sildenafil (which is also sold as Viagra), and a potentially serious drug interaction.

Finally, the newsletter contains a reminder on the importance of reporting adverse reactions to antiviral medications used for managing influenza A (H1N1), as well as a quarterly summary of health professional and consumer advisories.

The October 2009 edition ( of CARN can be viewed on the Health Canada website.

Contact Information

  • Health Canada
    Media Relations